Between 3 to 20 percent of women with breast cancer will develop another primary cancer tumor in the opposite breast within ten years of the first diagnosis. Though previous studies have identified some environmental, genetic, and treatment-related risk factors for contralateral breast cancer, scientists still don’t fully understand what causes these second primary cancers.
Read MoreTags: Fred Hutchinson Cancer Research Center, breast cancer, Research Funding, Hutch, Cancer Center, cancer research funding, laboratory suppliers, Fred Hutch, BioResearch Product Faire, Biotechnology trade show, 2017 research funding
In March, the National Cancer Institute (NCI) approved a $3.7 million, five-year grant to extend Dr. Eric Chow’s research into improving treatment of cardiovascular risk factors in childhood cancer survivors. Dr. Chow is a clinical researcher, epidemiologist, and pediatric oncologist at Fred Hutchinson Cancer Research Center in Seattle, Washington. This is one of two research grants to be awarded to Dr. Chow by the National Cancer Institute. The NCI also chose to extend Dr. Chow’s study of the long-term efficacy of a medication meant to minimize or prevent heart injury in pediatric patients going through chemotherapy. This $2.7 million in research funding will allow for four more years of studies regarding the use of dexrazoxane in pediatric cancer patients.
Read MoreTags: Fred Hutchinson Cancer Research Center, Pediatric Cancer Research, Research Funding, Hutch, Cancer Center, cancer research funding, laboratory suppliers, Fred Hutch, BioResearch Product Faire, Biotechnology trade show, general lab supply, 2017 research funding
The University of Minnesota has been awarded a five-year $8.2 million grant from the The National Cancer Institute (NCI) to develop a cell migration simulator that will predict how cancer cells move throughout the body.
Read MoreTags: University of Minnesota, cancer research, Minnesota, University of Minnesota Twin Cities, Research Funding, MN, UMinn, Midwest Region, new research grant, cancer research funding
According to the American Cancer Society, nearly 1 in 8 women will develop breast cancer in their lives, making it the second most common cancer for American women. However, breast cancer does not affect all women equally. Past studies have shown that women of African descent with breast cancer die at a higher rate than white women. Researchers at the University of Southern California Keck School of Medicine have received a grant of $12 million from the National Cancer Institute (NCI) to study the disparities in breast cancer in women.
Read MoreTags: CA, University of Southern California, breast cancer research, California, USC, BioResearch Product Faire Event, NIH grant, cancer research funding, 2016
A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.
Read MoreTags: CA, University of California Los Angeles, Stem Cells, Los Angeles, genetic engineering, UCLA, Biotechnology Vendor Showcase, new funding, cancer research funding, tumor cells
Pancreatic cancer is one of the most rapidly spreading cancers known to man, which translates to seriously staggering death rates. According to the American Cancer Society, for all stages of pancreatic cancer combined, the one-year relative survival rate is 20%, and the five-year rate is 6%, in part because more than 80% of patient tumors have spread beyond the pancreas by the time of diagnosis. In most cases, the cancer has already spread to the point where surgical removal is impossible. (Image: Test Molecule; Los Angeles Mission College)
Read MoreTags: Fred Hutchinson Cancer Research Center, Washington, cancer research, Cancer, 2015, BioResearch Product Faire Event, Seattle, NIH funding, Northwest Region, Hutch, cancer research funding
Scientists at Harvard Medical have made a recent breakthrough in cancer therapy research with the help of three separate grants from the National Institutes of Health, totaling over $1,153,000.
Read MoreTags: Harvard University, breast cancer research, cancer research, Massachusetts, Longwood Medical Center, 2015, Boston, BioResearch Product Faire Event, Harvard Medical, MA, Harvard, NIH funding, research grants, breast cancer funding, NIH grants, cancer research funding, best lab supply tradeshows, best science tradeshows
When life gives you lemons, make lemonade… and if you’ve got lemonade, make a lemonade stand. However, when Alex’s Lemonade Stand Foundation gives you millions in research funding, now you can help cure childhood cancer. Thanks to a little girl who once made lemonade to raise money for childhood cancer research, two UC San Francisco faculty members are among researchers being nationally acknowledged for their work in pediatric oncology.
Read MoreTags: CA, Bioresearch funding, Leukemia, California, Pediatric Cancer Research, grants, 2015, Biotechnology, Life Science, UCSF, San Francisco at Mission Bay, cancer research funding, Biotechnology Vendor Showcase Event
Science researcher C. David Allis is head of the Laboratory of Chromatin Biology and Epigenetics at Rockefeller University, and he has been awarded a $1 million grant from the Starr Cancer Consortium. As the leader of one of five cancer research teams from New York City based members of the consortium, Allis was one of 27 people to submit a grant application and a member of one of five collaborative cancer research teams selected as a winner. The Starr Cancer Consortium gave out a total of $5 million dollars over two years.
Tags: 2014, Rockefeller University, 2013, Northeast, New York, RockU, BioResearch Product Faire Event, NY, cancer research funding, cancer research grant